Article
Deep sequencing identifies novel regulatory variants in the distal promoter region of the dopamine-β-hydroxylase gene.
Pharmacogenetics and genomics - 1 Jul 2016
Punchaichira Toyanji J, Prasad Suman, Deshpande Smita N, Thelma B K
Abstract excerpt
OBJECTIVE: Dopamine-β-hydroxylase (DBH), an enzyme that converts dopamine into norepinephrine, is a drug target in cardiovascular and neuropsychiatric disorders. We aimed to identify functional variants in this gene by deep sequencing and enzyme phenotyping in an Indian cohort. MATERIALS AND METHODS: Targeted resequencing of 12 exons and 10 kb upstream sequences of DBH in healthy volunteers (n=50) was performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
